About this event
Wednesday, July 30, 2025 | 11:00 AM EST/ 4 PM BST
As the number of GLP-1 trials rapidly expands—spanning cardiometabolic, obesity, and emerging indications—clinical operations teams are including more technology and devices across trials than ever before. One key consideration is determining whether blood glucose meters (BGM) or continuous glucose monitors (CGM) are better suited to support data collection and clinical endpoints within the trial and patient population.
Join YPrime experts for a conversation on BGM vs. CGM, not just from an eCOA perspective, but through the lens of patient experience, trial design, data integrity, cost implications, and real-world site usability. Discover how both modalities can serve different trial needs, and the importance of eCOA integration with wearables and connected devices to enable sponsors to adopt BGM or CGM when it aligns with their study goals, timeline, and operational requirements.
This webinar will explore:
Hosted by
Karl is an accomplished scientist and business leader who has led global projects with an emphasis on patient-centered outcomes across a diverse range of diseases and therapeutic areas. He has more than 12 years’ experience in clinical research, having worked for pharmaceutical companies/sponsors, as well as clinical technology providers. He has working knowledge of eCOA, eConsent, translations, licensing, and library management. Karl is Industry Co-Director of the Critical Path Institute eCOA Consortium for 2025. He obtained a BSc (honors) degree in Industrial Microbiology, and later a PhD in Neuroscience from University College Dublin, with his doctoral work focused on the Prion protein and its role in neurodegeneration.
As a Senior Product Director with 12 years of experience in the eCOA industry, Aubrey Verna has been instrumental in steering product development and innovation at YPrime. Aubrey's experience is distinguished by a steadfast dedication to enhancing patient-centric trials through cutting-edge eCOA solutions, ensuring data integrity and adherence to regulatory standards. Aubrey's pivotal contributions include crafting tailored solutions to meet the complex demands of clinical trials. With a user-centric approach to product management, Aubrey emphasizes experience design to foster meaningful user engagement. Aubrey's journey at YPrime and within her career showcases a blend of strategic foresight, technical expertise, and a fervent drive to propel the industry forward.
Livestorm is a software company that provides a browser-based online web conferencing software for webinars and virtual meetings. Livestorm is the end-to-end video engagement platform enabling organizations to create on-demand, live, or pre-recorded ev...
